Australian Clinical Evidence Guidance Tackles 'A Leading Cause' Of Rejections For Medtech
This article was originally published in SRA
Executive Summary
Australia's Therapeutic Goods Administration is seeking to clarify for medical device makers its expectations for clinical evidence, the inadequacy of which has apparently been a leading cause of rejection of registration applications in the country, especially for higher risk devices.